Jushi Holdings (OTCPK:JUSH.F) Quarterly Loss Of US$23.7 Million Tests Bullish Margin Narratives

Simply Wall St.04-03

AdvertisementJushi Holdings FY 2025 results in focus Jushi Holdings (OTCPK:JUSH.F) has reported third quarter FY 2025 revenue of US$65.7 million with a basic EPS loss of US$0.12, while trailing twelve...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2624633758?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","is_english":true,"pubTime":"2026-04-03 07:32","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2624633758","market":"us","top_or_hot":-1,"title":"Jushi Holdings (OTCPK:JUSH.F) Quarterly Loss Of US$23.7 Million Tests Bullish Margin Narratives","media":"Simply Wall St.","content":"<div>\n<p>AdvertisementJushi Holdings FY 2025 results in focus Jushi Holdings (OTCPK:JUSH.F) has reported third quarter FY 2025 revenue of US$65.7 million with a basic EPS loss of US$0.12, while trailing twelve...</p>\n\n<a href=\"https://simplywall.st/stocks/us/pharmaceuticals-biotech/otc-jush.f/jushi-holdings/news/jushi-holdings-otcpkjushf-quarterly-loss-of-us237-million-te\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Jushi Holdings (OTCPK:JUSH.F) Quarterly Loss Of US$23.7 Million Tests Bullish Margin Narratives</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJushi Holdings (OTCPK:JUSH.F) Quarterly Loss Of US$23.7 Million Tests Bullish Margin Narratives\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-04-03 07:32 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/pharmaceuticals-biotech/otc-jush.f/jushi-holdings/news/jushi-holdings-otcpkjushf-quarterly-loss-of-us237-million-te><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>AdvertisementJushi Holdings FY 2025 results in focus Jushi Holdings (OTCPK:JUSH.F) has reported third quarter FY 2025 revenue of US$65.7 million with a basic EPS loss of US$0.12, while trailing twelve...</p>\n\n<a href=\"https://simplywall.st/stocks/us/pharmaceuticals-biotech/otc-jush.f/jushi-holdings/news/jushi-holdings-otcpkjushf-quarterly-loss-of-us237-million-te\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4112","symbol_name":"金融交易所和数据","start_time":0,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/otc-jush.f/jushi-holdings/news/jushi-holdings-otcpkjushf-quarterly-loss-of-us237-million-te","article_id":"2624633758","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/otc-jush.f/jushi-holdings/news/jushi-holdings-otcpkjushf-quarterly-loss-of-us237-million-te","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2624633758","pubTimestamp":1775172753,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Jushi Holdings FY 2025 results in focus\nJushi Holdings (OTCPK:JUSH.F) has reported third quarter FY 2025 revenue of US$65.7 million with a basic EPS loss of US$0.12, while trailing twelve month revenue stands at US$260.4 million and a basic EPS loss of US$0.34. Over recent quarters, the company has seen quarterly revenue range from US$61.6 million to US$65.9 million, alongside basic EPS losses between US$0.01 and US$0.12. This keeps the spotlight firmly on how efficiently each dollar of sales...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4112":"金融交易所和数据","JUSHF":"Jushi Holdings Inc.","BLSX":"Tradr 2X Long BLSH Daily ETF","BLSG":"2倍做多BLSH ETF-Leverage Shares"},"translate_title":"巨石控股(OTCPK：JUSH.F)季度亏损2370万美元考验看涨利润率叙事","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"JUSHF":1.98,"BLSX":0.6,"BLSG":0.6},"content_text":"AdvertisementJushi Holdings FY 2025 results in focus Jushi Holdings (OTCPK:JUSH.F) has reported third quarter FY 2025 revenue of US$65.7 million with a basic EPS loss of US$0.12, while trailing twelve month revenue stands at US$260.4 million and a basic EPS loss of US$0.34. Over recent quarters, the company has seen quarterly revenue range from US$61.6 million to US$65.9 million, alongside basic EPS losses between US$0.01 and US$0.12. This keeps the spotlight firmly on how efficiently each dollar of sales is translating through the income statement. For investors, the latest print centers on how these steady top line figures compare with ongoing losses and what that indicates about Jushi Holdings' margin profile. See our full analysis for Jushi Holdings. With the headline numbers on the table, the next step is to weigh them against the most common narratives around Jushi Holdings to see which stories the data supports and which ones start to look stretched. See what the community is saying about Jushi Holdings OTCPK:JUSH.F Earnings & Revenue History as at Apr 2026 US$65.7 million in sales, but US$23.7 million net loss keeps margins under pressure  For Q3 FY 2025, Jushi booked US$65.7 million of revenue against a net loss of US$23.7 million, while trailing twelve month revenue sits at US$260.4 million with a total loss of US$65.5 million. This shows that losses remain sizeable relative to sales even as the top line stays in a tight band around US$60 million to US$66 million a quarter. Analysts' consensus view highlights opportunities from adult use rollouts and retail expansion, yet the current loss profile creates tension with that story.\n     The consensus narrative talks about higher revenue and margin potential from factors such as expanded retail footprints and product launches. However, the latest basic EPS loss of US$0.12 this quarter and US$0.34 over the trailing twelve months underlines that the business is still some distance from the profitability implied in those expectations. Comments about margin expansion sit against data showing a trailing twelve month loss of US$65.5 million on US$260.4 million of revenue, so any upside case has to account for the size of the gap that still needs to be closed.    Curious how this earnings profile lines up with the broader story investors are debating around Jushi Holdings, including growth, risks, and valuation narratives over time? See what the community is saying about Jushi Holdings DCF fair value and P/S of 0.4x contrast with US$0.54 share price  The shares trade at US$0.54 against a DCF fair value of US$0.72 and an analyst price target of US$1.00, while the P/S multiple is 0.4x compared with 4.6x for the wider US pharmaceuticals group and 1.1x for peers. This places valuation firmly at the low end of the range highlighted in the analysis. Supporters of the bullish narrative often point to this valuation gap, but the earnings track record makes that case more demanding.\n     The bullish side leans on expectations of future revenue growth and margin improvement, yet the company currently reports a trailing twelve month loss of US$65.5 million and is not forecast to turn profitable within the next three years. As a result, the low P/S has to be weighed against the absence of near term earnings. At the same time, revenue growth of 10.3% over the last year, roughly in line with the 10.4% US market benchmark cited, shows the business is adding sales. This is the key pillar bulls use to argue that today’s discounted P/S and gap to both DCF fair value and the US$1.00 target may reflect the market pricing in these profitability risks.    Do you want to see how bullish investors connect these low multiples to the long term growth story they expect to play out for Jushi Holdings? 🐂 Jushi Holdings Bull Case Negative equity and ongoing losses anchor the cautious view  The risk analysis flags negative shareholders’ equity alongside persistent net losses, with trailing twelve month net income excluding extra items at a loss of US$65.5 million on US$260.4 million of revenue. The balance sheet and income statement therefore both sit in loss making territory despite reported progress in reducing losses by an average of 18.7% per year over five years. Cautious investors focus heavily on these capital structure and profitability metrics, and the latest figures give that bearish framing plenty to work with.\n     Bears highlight that the company is still unprofitable and not projected to reach profitability within three years, while also carrying negative equity. Together, these points raise questions about how future growth or refinancing will be funded if losses continue at the current scale. The analysis also notes relatively volatile share price behavior over the past three months. Combined with the ongoing loss profile and negative equity, this helps explain why some investors treat the current discount to DCF fair value and the US$1.00 target as a risk premium rather than a clear mispricing.    Skeptics argue that balance sheet pressure and continued losses are central to the story, so it helps to see their thesis laid out in one place through 🐻 Jushi Holdings Bear Case Next Steps To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Jushi Holdings on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves. With both risks and rewards on the table, sentiment around Jushi Holdings is clearly split. Move quickly, review the numbers yourself, and weigh the balance of 2 key rewards and 3 important warning signs. See What Else Is Out There Jushi Holdings is still posting sizeable losses on US$260.4 million of trailing twelve month revenue, with negative equity keeping the risk profile elevated. If that mix of ongoing losses and balance sheet pressure feels like a lot of risk for your portfolio, consider shifting some attention toward 67 resilient stocks with low risk scores for companies where financial resilience is front and center.  This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.39.0","shortVersion":"4.39.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2624633758","isCrawlerRequest":true}